Valuation: IRADIMED CORPORATION

Market Cap 1.31B 1.14B 1.05B 978M 1.86B 124B 1.89B 12.65B 4.92B 61.25B 4.91B 4.8B 212B P/E 2026 *
53.6x
P/E 2027 * 47.3x
Enterprise Value 1.31B 1.14B 1.05B 978M 1.86B 124B 1.89B 12.65B 4.92B 61.25B 4.91B 4.8B 212B EV / Sales 2026 *
14.3x
EV / Sales 2027 * 13x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-2.01%
1 week+4.90%
Current month+4.90%
1 month+6.20%
3 months+7.22%
6 months+1.93%
Current year+3.04%
1 week 94.8
Extreme 94.8
102.99
1 month 89.69
Extreme 89.69
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Director/Board Member 73 31/12/2013
Director/Board Member 61 01/09/2025
Director/Board Member 70 31/12/2018
Date Insider Type Main position Quantity % Market Cap.
06-19Fiscal year

Chief Financial Officer

13,911 0.1088%
06-03Sell

Director

-3,000 0.0235%
05-31Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-2.01%+4.90%+69.84%+114.88% 1.31B
-2.76%+1.73%-17.89%-27.19% 12.88B
+2.94%+1.54%+87.63%+10.36% 4.81B
-4.95%+1.80%-34.31%-63.42% 1.24B
-3.17%+0.48%-39.79%-48.51% 1.11B
-3.85%-1.06%-46.04% - 916M
-6.68%-9.58%+158.67%+143.84% 662M
-14.22%-25.20%+35.32% - 330M
-1.87%-2.90%-55.17%+209.67% 257M
-1.67%-1.67%-26.58%-43.62% 141M
Average -3.82%-2.61%+13.17%+37.00% 2.37B
Weighted average by Cap. -1.99%-1.91%+10.67%-6.23%

Financials

2026 *2027 *
Net sales 91.2M 79.81M 73.55M 68.17M 129M 8.66B 132M 882M 343M 4.27B 342M 335M 14.77B 101M 88.3M 81.37M 75.42M 143M 9.58B 145M 976M 379M 4.73B 379M 371M 16.34B
Net income 24.55M 21.48M 19.8M 18.35M 34.84M 2.33B 35.4M 237M 92.33M 1.15B 92.17M 90.17M 3.97B 27.8M 24.33M 22.42M 20.78M 39.45M 2.64B 40.08M 269M 105M 1.3B 104M 102M 4.5B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
07/07/26 US$100.24 -2.01% 113,696
06/07/26 US$102.30 +1.32% 110,886
02/07/26 US$100.97 +2.99% 130,062
01/07/26 US$98.04 +2.60% 154,909
30/06/26 US$95.56 +1.58% 109,602
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
102.30USD
Average target price
118.00USD
Spread / Average Target
+15.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock